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Abstract
Clinical NLP has an immense potential in
contributing to how clinical practice will
be revolutionized by the advent of large
scale processing of clinical records. How-
ever, this potential has remained largely
untapped due to slow progress primarily
caused by strict data access policies for re-
searchers. In this paper, we discuss the
concern for privacy and the measures it
entails. We also suggest sources of less
sensitive data. Finally, we draw attention
to biases that can compromise the validity
of empirical research and lead to socially
harmful applications.
1 Introduction
The use of notes written by healthcare providers
in the clinical settings has long been rec-
ognized to be a source of valuable infor-
mation for clinical practice and medical re-
search. Access to large quantities of clinical
reports may help in identifying causes of dis-
eases, establishing diagnoses, detecting side ef-
fects of beneficial treatments, and monitoring
clinical outcomes (Agus, 2016; Goldacre, 2014;
Murdoch and Detsky, 2013). The goal of clini-
cal natural language processing (NLP) is to de-
velop and apply computational methods for lin-
guistic analysis and extraction of knowledge from
free text reports (Demner-Fushman et al., 2009;
Hripcsak et al., 1995; Meystre et al., 2008). But
while the benefits of clinical NLP and data min-
ing have been universally acknowledged, progress
in the development of clinical NLP techniques has
been slow. Several contributing factors have been
identified, most notably difficult access to data,
limited collaboration between researchers from
different groups, and little sharing of implemen-
tations and trained models (Chapman et al., 2011).
For comparison, in biomedical NLP, where the
working data consist of biomedical research litera-
ture, these conditions have been present to a much
lesser degree, and the progress has been more
rapid (Cohen and Demner-Fushman, 2014). The
main contributing factor to this situation has been
the sensitive nature of data, whose processing may
in certain situations put patient’s privacy at risk.
The ethics discussion is gaining momentum in
general NLP (Hovy and Spruit, 2016). We aim in
this paper to gather the ethical challenges that are
especially relevant for clinical NLP, and to stim-
ulate discussion about those in the broader NLP
community. Although enhancing privacy through
restricted data access has been the norm, we do
not only discuss the right to privacy, but also draw
attention to the social impact and biases emanat-
ing from clinical notes and their processing. The
challenges we describe here are in large part not
unique to clinical NLP, and are applicable to gen-
eral data science as well.
2 Sensitivity of data and privacy
Because of legal and institutional concerns arising
from the sensitivity of clinical data, it is difficult
for the NLP community to gain access to relevant
data (Barzilay, 2016; Friedman et al., 2013). This
is especially true for the researchers not connected
with a healthcare organization. Corpora with trans-
parent access policies that are within reach of
NLP researchers exist, but are few. An often
used corpus is MIMICII(I) (Johnson et al., 2016;
Saeed et al., 2011). Despite its large size (cover-
ing over 58,000 hospital admissions), it is only
representative of patients from a particular clini-
cal domain (the intensive care in this case) and ge-
ographic location (a single hospital in the United
States). Assuming that such a specific sample is
representative of a larger population is an exam-
ple of sampling bias (we discuss further sources
of bias in section 3). Increasing the size of a sam-
ple without recognizing that this sample is atypical
for the general population (e.g. not all patients are
critical care patients) could also increase sampling
bias (Kaplan et al., 2014).1 We need more large
corpora for various medical specialties, narrative
types, as well as languages and geographic areas.
Related to difficult access to raw clinical data
is the lack of available annotated datasets for
model training and benchmarking. The reality
is that annotation projects do take place, but are
typically constrained to a single healthcare or-
ganization. Therefore, much of the effort put
into annotation is lost afterwards due to impos-
sibility of sharing with the larger research com-
munity (Chapman et al., 2011; Fan et al., 2011).
Again, exceptions are either few—e.g. THYME
(Styler IV et al., 2014), a corpus annotated with
temporal information—or consist of small datasets
resulting from shared tasks like the i2b2 and
ShARe/CLEF. In addition, stringent access poli-
cies hamper reproduction efforts, impede scien-
tific oversight and limit collaboration, not only be-
tween institutions but also more broadly between
the clinical and NLP communities.
There are known cases of datasets that had
been used in published research (including re-
production) in its full form, like MiPACQ2,
Blulab, EMC Dutch Clinical Corpus and 2010
i2b2/VA (Albright et al., 2013; Kim et al., 2015;
Afzal et al., 2014; Uzuner et al., 2011), but were
later trimmed down or made unavailable, likely
due to legal issues. Even if these datasets were still
available in full, their small size is still a concern,
and the comments above regarding sampling bias
certainly apply. For example, a named entity rec-
ognizer trained on 2010 i2b2/VA data, which con-
sists of 841 annotated patient records from three
different specialty areas, will due to its size only
contain a small portion of possible named entities.
Similarly, in linking clinical concepts to an ontol-
ogy, where the number of output classes is larger
(Pradhan et al., 2013), the small amount of train-
ing data is a major obstacle to deployment of sys-
1Sampling bias could also be called selection bias; it is
not inherent to the individual documents, but stems from the
way these are arranged into a single corpus.
2The access to the MiPACQ corpus will be re-enabled in
the future within the Health NLP Center for distributing lin-
guistic annotations of clinical texts (Guergana Savova, per-
sonal communication).
tems suitable for general use.
2.1 Protecting the individual
Clinical notes contain detailed information about
patient-clinician encounters in which patients con-
fide not only their health complaints, but also their
lifestyle choices and possibly stigmatizing condi-
tions. This confidential relationship is legally pro-
tected in US by the HIPAA privacy rule in the case
of individuals’ medical data. In EU, the conditions
for scientific usage of health data are set out in the
General Data Protection Regulation (GDPR). San-
itization of sensitive data categories and individu-
als’ informed consent are in the forefront of those
legislative acts and bear immediate consequences
for the NLP research.
The GDPR lists general principles relating to
processing of personal data, including that pro-
cessing must be lawful (e.g. by means of con-
sent), fair and transparent; it must be done for ex-
plicit and legitimate purposes; and the data should
be kept limited to what is necessary and as long
as necessary. This is known as data minimiza-
tion, and it includes sanitization. The scientific
usage of health data concerns “special categories
of personal data”. Their processing is only al-
lowed when the data subject gives explicit consent,
or the personal data is made public by the data
subject. Scientific usage is defined broadly and
includes technological development, fundamental
and applied research, as well as privately funded
research.
Sanitization Sanitization techniques are often
seen as the minimum requirement for protect-
ing individuals’ privacy when collecting data
(Berman, 2002; Velupillai et al., 2015). The goal
is to apply a procedure that produces a new ver-
sion of the dataset that looks like the original for
the purposes of data analysis, but which maintains
the privacy of those in the dataset to a certain
degree, depending on the technique. Documents
can be sanitized by replacing, removing or oth-
erwise manipulating the sensitive mentions such
as names and geographic locations. A distinc-
tion is normally drawn between anonymization,
pseudonymization and de-identification. We refer
the reader to Polonetsky et al. (2016) for an excel-
lent overview of these procedures.
Although it is a necessary first step in protect-
ing the privacy of patients, sanitization has been
criticized for several reasons. First, it affects
the integrity of the data, and as a consequence,
their utility (Duquenoy et al., 2008). Second,
although sanitization in principle promotes data
access and sharing, it may often not be suffi-
cient to eliminate the need for consent. This
is largely due to the well-known fact that orig-
inal sensitive data can be re-identified through
deductive disclosure (Amblard et al., 2014;
De Mazancourt et al., 2015; Hardt et al., 2016;
Malin et al., 2013; Tene, 2011).3 Finally, sanitiza-
tion focuses on protecting the individual, whereas
ethical harms are still possible on the group level
(O’Doherty et al., 2016; Taylor et al., 2017). In-
stead of working towards increasingly restrictive
sanitization and access measures, another course
of action could be to work towards heightening
the perception of scientific work, emphasizing pro-
fessionalism and existence of punitive measures
for illegal actions (Fairfield and Shtein, 2014;
Mittelstadt and Floridi, 2016).
Consent Clinical NLP typically requires a large
amount of clinical records describing cases of pa-
tients with a particular condition. Although obtain-
ing consent is a necessary first step, obtaining ex-
plicit informed consent from each patient can also
compromise the research in several ways. First,
obtaining consent is time consuming by itself, and
it results in financial and bureaucratic burdens. It
can also be infeasible due to practical reasons such
as a patient’s death. Next, it can introduce bias as
those willing to grant consent represent a skewed
population (Nyre´n et al., 2014). Finally, it can be
difficult to satisfy the informedness criterion: In-
formation about the experiment sometimes can not
be communicated in an unambiguous way, or ex-
periments happen at speed that makes enacting in-
formed consent extremely hard (Bird et al., 2016).
The alternative might be a default opt-in pol-
icy with a right to withdraw (opt-out). Here, con-
sent can be presumed either in a broad manner—
allowing unspecified future research, subject
to ethical restrictions—or a tiered manner—
allowing certain areas of research but not others
(Mittelstadt and Floridi, 2016; Terry, 2012). Since
the information about the intended use is no longer
uniquely tied to each research case but is more
general, this could facilitate the reuse of datasets
3Additionaly, it may be due to organizational skepticism
about the effectiveness of sanitization techniques, although
it has been shown that automated de-identification systems
for English perform on par with manual de-identification
(Deleger et al., 2013).
by several research teams, without the need to
ask for consent each time. The success of imple-
menting this approach in practice is likely to de-
pend on public trust and awareness about possible
risks and opportunities. We also believe that a dis-
tinction between academic research and commer-
cial use of clinical data should be implemented,
as the public is more willing to allow research
than commercial exploitation (Lawrence, 2016;
van Staa et al., 2016).
Yet another possibility is open consent, in which
individuals make their data publicly available. Ini-
tiatives like Personal Genome Project may have
an exemplary role, however, they can only provide
limited data and they represent a biased population
sample (Mittelstadt and Floridi, 2016).
Secure access Since withholding data from re-
searchers would be a dubious way of ensuring con-
fidentiality (Berman, 2002), the research has long
been active on secure access and storage of sensi-
tive clinical data, and the balance between the de-
gree of privacy loss and the degree of utility. This
is a broad topic that is outside the scope of this ar-
ticle. The interested reader can find the relevant
information in Dwork and Pottenger (2013), Ma-
lin et al. (2013) and Rindfleisch (1997).
Promotion of knowledge and application of
best-of-class approaches to health data is seen
as one of the ethical duties of researchers
(Duquenoy et al., 2008; Lawrence, 2016). But for
this to be put in practice, ways need to be guar-
anteed (e.g. with government help) to provide re-
searchers with access to the relevant data. Re-
searchers can also go to the data rather than have
the data sent to them. It is an open question
though whether medical institutions—especially
those with less developed research departments—
can provide the infrastructure (e.g. enough CPU
and GPU power) needed in statistical NLP. Also,
granting access to one healthcare organization at
a time does not satisfy interoperability (cross-
organizational data sharing and research), which
can reduce bias by allowing for more complete in-
put data. Interoperability is crucial for epidemiol-
ogy and rare disease research, where data from one
institution can not yield sufficient statistical power
(Kaplan et al., 2014).
Are there less sensitive data? One criterion
which may have influence on data accessibility is
whether the data is about living subjects or not.
The HIPAA privacy rule under certain conditions
allows disclosure of personal health information of
deceased persons, without the need to seek IRB
agreement and without the need for sanitization
(Huser and Cimino, 2014). It is not entirely clear
though how often this possibility has been used in
clinical NLP research or broader.
Next, the work on surrogate data has re-
cently seen a surge in activity. Increasingly more
health-related texts are produced in social media
(Abbasi et al., 2014), and patient-generated data
are available online. Admittedly, these may not
resemble the clinical discourse, yet they bear to
the same individuals whose health is documented
in the clinical reports. Indeed, linking individu-
als’ health information from online resources to
their health records to improve documentation is
an active line of research (Padrez et al., 2015). Al-
though it is generally easier to obtain access to
social media data, the use of social media still
requires similar ethical considerations as in the
clinical domain. See for example the influen-
tial study on emotional contagion in Facebook
posts by Kramer et al. (2014), which has been
criticized for not properly gaining prior consent
from the users who were involved in the study
(Schroeder, 2014).
Another way of reducing sensitivity of data and
improving chances for IRB approval is to work
on derived data. Data that can not be used to
reconstruct the original text (and when sanitized,
can not directly re-identify the individual) include
text fragments, various statistics and trained mod-
els. Working on randomized subsets of clinical
notes may also improve the chances of obtaining
the data. When we only have access to trained
models from disparate sources, we can refine them
through ensembling and creation of silver standard
corpora, cf. Rebholz-Schuhmann et al. (2011).
Finally, clinical NLP is also possible on veteri-
nary texts. Records of companion animals are
perhaps less likely to involve legal issues, while
still amounting to a large pool of data. As an
example, around 40M clinical documents from
different veterinary clinics in UK and Australia
are stored centrally in the VetCompass repository.
First NLP steps in this direction were described in
the invited talk at the Clinical NLP 2016 workshop
(Baldwin, 2016).
3 Social impact and biases
Unlocking knowledge from free text in the health
domain has a tremendous societal value. How-
ever, discrimination can occur when individuals
or groups receive unfair treatment as a result of
automated processing, which might be a result of
biases in the data that were used to train mod-
els. The question is therefore what the most im-
portant biases are and how to overcome them,
not only out of ethical but also legal responsi-
bility. Related to the question of bias is so-
called algorithm transparency (Goodman, 2016;
Kamarinou et al., 2016), as this right to explana-
tion requires that influences of bias in training data
are charted. In addition to sampling bias, which
we introduced in section 2, we discuss in this sec-
tion further sources of bias. Unlike sampling bias,
which is a corpus-level bias, these biases here are
already present in documents, and therefore hard
to account for by introducing larger corpora.
Data quality Texts produced in the clinical set-
tings do not always tell a complete or accurate pa-
tient story (e.g. due to time constraints or due to
patient treatment in different hospitals), yet impor-
tant decisions can be based on them.4 As language
is situated, a lot of information may be implicit,
such as the circumstances in which treatment de-
cisions are made (Hersh et al., 2013). If we fail
to detect a medical concept during automated pro-
cessing, this can not necessarily be a sign of nega-
tive evidence.5 Work on identifying and imputing
missing values holds promise for reducing incom-
pleteness, see Lipton et al. (2016) for an example
in sequential modeling applied to diagnosis classi-
fication.
Reporting bias Clinical texts may include bias
coming from both patient’s and clinician’s report-
ing. Clinicians apply their subjective judgments
to what is important during the encounter with pa-
tients. In other words, there is separation between,
on the one side, what is observed by the clinician
and communicated by the patient, and on the other,
4A way to increase data completeness and reduce selec-
tion bias is the use of nationwide patient registries, as known
for example in Scandinavian countries (Schmidt et al., 2015).
5We can take timing-related “censoring” effects as an ex-
ample. In event detection, events prior to the start of an obser-
vation may be missed or are uncertain, which means that the
first appearance of a diagnosis in the clinical record may not
coincide with the occurrence of the disease. Similarly, key
events after the end of the observation may be missing (e.g.
death, when it occurred in another institution).
what is noted down. Cases of more serious illness
may be more accurately documented as a result of
clinician’s bias (increased attention) and patient’s
recall bias. On the other hand, the cases of stig-
matized diseases may include suppressed informa-
tion. In the case of traffic injuries, documentation
may even be distorted to avoid legal consequences
(Indrayan, 2013).
We need to be aware that clinical notes may re-
flect health disparities. These can originate from
prejudices held by healthcare practitioners which
may impact patients’ perceptions; they can also
originate from communication difficulties in the
case of ethnic differences (Zestcott et al., 2016).
Finally, societal norms can play a role. Brady et al.
(2016) find that obesity is often not documented
equally well for both sexes in weight-addressing
clinics. Young males are less likely to be recog-
nized as obese, possibly due to societal norms see-
ing them as “stocky” as opposed to obese. Unless
we are aware of such bias, we may draw premature
conclusions about the impact of our results.
It is clear that during processing of clinical texts,
we should strive to avoid reinforcing the biases. It
is difficult to give a solution on how to actually
reduce the reporting bias after the fact. One pos-
sibility might be to model it. If we see clinical re-
ports as noisy annotations for the patient story in
which information is left-out or altered, we could
try to decouple the bias from the reports. Inspira-
tion could be drawn, for example, from the work
on decoupling reporting bias from annotations in
visual concept recognition (Misra et al., 2016).
Observational bias Although variance in health
outcome is affected by social, environmental and
behavioral factors, these are rarely noted in clini-
cal reports (Kaplan et al., 2014). The bias of miss-
ing explanatory factors because they can not be
identified within the given experimental setting is
also known as the streetlight effect. In certain
cases, we could obtain important prior knowledge
(e.g. demographic characteristics) from data other
than clinical notes.
Dual use We have already mentioned linking
personal health information from online texts to
clinical records as a motivation for exploring sur-
rogate data sources. However, this and many other
applications also have potential to be applied in
both beneficial and harmful ways. It is easy to
imagine how sensitive information from clinical
notes can be revealed about an individual who
is present in social media with a known identity.
More general examples of dual use are when the
NLP tools are used to analyze clinical notes with
a goal of determining individuals’ insurability and
employability.
4 Conclusion
In this paper, we reviewed some challenges that
we believe are central to the work in clinical NLP.
Difficult access to data due to privacy concerns has
been an obstacle to progress in the field. We have
discussed how the protection of privacy through
sanitization measures and the requirement for in-
formed consent may affect the work in this do-
main. Perhaps, it is time to rethink the right to pri-
vacy in health in the light of recent work in ethics
of big data, especially its uneasy relationship to
the right to science, i.e. being able to benefit
from science and participate in it (Tasioulas, 2016;
Verbeek, 2014). We also touched upon possible
sources of bias that can have an effect on the ap-
plication of NLP in the health domain, and which
can ultimately lead to unfair or harmful treatment.
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